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ChromatogramAbstract Cannabis is the most frequently used drug of abuse not only in Pakistan but also in the
whole world. Its use is increasing drastically every year. GCMS allows for the analysis of Cannabis
sativa which shows the differences of the constituents of this plant. Prevalence of this plant can be
identiﬁed through knowledge of its constituents. In this way we can obstruct the production if we
know the region in which it is produced. GCMS is a useful technique for the comparison of con-
stituents of this drug of abuse which will assist the investigator concerning the origin of plant.
Comparison also aids in the understanding and acquaintance of similarities of different samples
of cannabinoids.
ª 2014 The International Association of Law and Forensic Sciences (IALFS). Production and hosting by
Elsevier B.V. All rights reserved.1. Introduction
Cannabis products are the drugs most frequently used around
the world, representing 65 percent of all global seizure cases
(1.65 million cases) in 2011. 5200 tons of herbs and 1000 tons
of resin were seized in 2006. Virtually all countries in the world
are affected by cannabis trafﬁcking. Similarly, cannabis
remains the most widely used drug worldwide, with an esti-
mated 166 million people who have used cannabis in 2006,
equivalent to about 4 percent of the world’s population aged
15–64 years. At the end of the last century, the production
method for cannabis has become more complex, due to the
availability of many illicit market hemp products with very dif-
ferent levels of the main psychoactive ingredient, delta-9-tetrahydrocannabinol (THC). Recently, there has also been a
renewed debate about the increasing THC content (often
referred to as ‘‘power’’) in illicit cannabis products.
All this requires analytical data that are comparable in lab-
oratories and in time. However, most countries do not require
a detailed analysis of the law of the THC content of different
products, and such analyses are performed using various meth-
ods and experimental models, reducing the comparability of
results.1 Cannabis sativa derivates, like hashish and marijuana,
are the most commonly consumed illegal drugs worldwide.
The adverse health effects of cannabis have been debated,
but cannabis has been considered to have low toxicity and
abuse potential.3,4 Nevertheless, accumulating and converging
evidence during the last decade has, revealed that cannabis use
may be a risk factor for psychotic symptoms.5,6 The reason for
the increased number of such reports is not clear. There has,
however, been a great interest in whether the concentration
of D9-tetrahydrocannabinol (THC), the psychoactive com-
pound in cannabis, has increased in.4,7,8ll rights
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from C. sativa L. of which more than 60 are cannabinoids.
Cannabinoids are a characteristic class of substances unique
to Cannabis. The most abundant are D9-tetrahydrocannabi-
nol or THC (the main psychoactive cannabinoid), cannabidiol
(CBD), cannabigerol (CBG) and cannabichromene (CBC).10
The Cannabis herb, dried ﬂower buds of the female canna-
bis plants is consumed not only in almost every country in the
world, but also produced in most of the countries, cannabis
resin is lim- ited to a much smaller number of countries, most
of which are found in North Africa, the Middle East and
Southwest Asia.2
In 2011, themain countries listed as a source country of hash-
ish were Morocco, and Afghanistan and, to a lesser extent,
India, Lebanon and Pakistan (Pakistan, it is estimated that the
resin seized on its territory originated in Afghanistan).
Afghanistan and Morocco were determined as countries of ori-
gin of hashish between 2009 and 2011, and thus may reﬂect the
main markets for resin as Afghanistan and cannabis as
Morocco. Morocco has been named as the source of hashish
smuggled from 17 different countries, 11 of which are in
Western andCentral EuropeMorocco seems to remain themain
source of cannabis resin. Afghanistan, on the other hand, has
been named the country of origin of the cannabis resin seized
in neighboring countries and the countries of the North. The
countries of the Middle East and Europe also named
Afghanistan as a source of hashish seizures. Global distribution
reﬂects Afghanistan as the main source, as well. In the period
2000–2011, global cannabis resin seizures were dominated by
Spain, which is the main point of entry for Moroccan cannabis
resin in Europe. In 2011, Spain accounted for 34 percent of
global seizures, Pakistan 18 percent and Morocco 12 percent.2
2. Experimental
2.1. General
The rationale of experiment was to compare chemically and bio-
logically active components of C. sativa from different regions
of Pakistan. This study will make it possible to compare the
divergence of normal and protein bound cannabis from differ-
ent regions of Pakistan. For the intention of comparative anal-
ysis of different areas of cannabinoids, ﬁrst of all we performed
the extraction of cannabinoids in an organic solvent, n-hexane,
so that the impurities could be detached and these impurities
would not interfere with our results. After that we performed
color test just to make sure the presence of cannabinoids.
GCMS analysis of all four samples was carried out.
2.2. Equipment
Equipments used in this experiment include GCMS. GCMS
was used for the comparison of samples from different areas
of Pakistan.
3. Materials
Crude cannabis was obtained with the help of the Anti-
Narcotic Force, Pakistan (ANF) from Bhakkar, Kashmir,
Gujranwala and Chaman. The n-hexane, acetaldehyde,chloroform, vanillin, HCl, alcohol, acetone and ethyl ether
were purchased fromMerck. All of the solvents such as metha-
nol, acetone, n-hexane and ethyl acetate were of analytical
grade.
3.1. Extraction
25 gms of the plant was soaked in 500 ml n-hexane for 10 days.
Then it was sonicated and solvent was evaporated using a
rotary evaporator. Now the resultant sample is subjected to
analysis.
3.2. GCMS
After that we conducted GCMS analysis so that we could com-
pare the samples of Cannabis sativa from different areas. For
the purpose of GCMS we needed to do sample preparation
ﬁrst.
3.2.1. Sample preparation
Gas chromatography–mass spectrometry requires derivatiza-
tion of the samples for analysis. For this purpose, 500 micro-
liters of the solution was transferred to a 2 ml GC vial. The
vial was placed in a heating bath (150 C) for 12 min, wherein
the solvent was evaporated and decarboxylated. The residue
was dissolved in 1.5 ml of ethanol (analytical grade), the vial
was shaken well and the resulting solution was successfully
analyzed by gas chromatography which is abbreviated as GC.
Following are the conditions used
 Column: 15 m · 0.25 mm, 0.25 micron;
 Phase: 5% diphenyl–95% dimethyl polysiloxane
 Vector: a hydrogen atom, 1.1 ml/min, constant ﬂow
 Injector: split/inseparable, 280 C
 Division ratio: 20:01
 Oven: 2 min at 200 C, 10 C/min 200–240 C, 2 min at 240 C
 Detector: MS 300 C, H
 35 ml/min, air 350 ml/min
 Internal standard: tribenzylamine (TBA) in ethanol (0.5
mg/ml)
 Injection: 1.5 microliters, Split
 The order of elution: CBD, THC, CBN.1
4. Results
The results of GCMS analysis of the sample obtained from
Kashmir region of Pakistan are as follows:
Fig. 1 reveals that there are ﬁve different constituents pre-
sent in the cannabis plant obtained from the Kashmir region.
By searching the library of American Academy of Forensic
Science which is abbreviated as AAFS, the names of these con-
stituents was obtained. The peaks indicates that the abundance
of a constituent was different in each plant. It means the quan-
tity of each constituent present in the plant is different from
each other. The position of peaks shows the time of elution
which is different for each constituent because of it’s different
structures.
Fig. 2 shows the names of different constituents present in
the plant. There are ﬁve components which are present in the
Figure 1 GCMS of Kashmir sample.
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is phytol. It is an acyclic diterpene alcohol. Its molecular for-
mula is C10H20O. This can be commercially used in the fra-
grance industry. The second constituent is 9-
anthracenecarbonitrile.is the structure of this compound. Its molecular formula is
C15H9N. The third constituent is cannabidiol. It is one of the
major constituents of the cannabis plant. It is supposed to have
a wider scope than THC because of it is less psychoactive. Its
molecular formula is C21H30O2. It is used in the treatment of
nausea, convulsions, bipolar disorders, etc. The fourth con-
stituent is tetrahydrocannabinol also known as D9THC which
is considered the main or principal psychoactive constituent of
the cannabis plant. It is classiﬁed as schedule 1 under theconvention on psychotropic substances. It is available in a syn-
thetic form as well, its brand name is Marinol. It is a toxic
component and can cause death due to over dosing. The ﬁfth
constituent is cannabinol. It is usually present in or trace
amounts in C. sativa. It may be a metabolite of THC. Its
molecular formula is C21H26O2.
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Figure 2 Library search of Kashmir sample.
GCMS analysis of Cannabis sativa L. 117Following are the results of the GCMS analysis of the
Cannabis extract from the District of Bhakkar of Pakistan.
Fig. 3 shows that the samples taken from Bhakkar region
also contain ﬁve constituents. These Five constituents of
Bhakkar region are similar to those of the Kashmir region.
This was conﬁrmed by the AAFS library which is shown
in Fig. 4. All of the constituents showed similar RT val-
ues. From this, we can analyze that C. sativa of both
areas have similar constituents.
Following are the results of the GCMS analysis of the
Cannabis extract from the District of Gujranwala of
Pakistan.
Fig. 5 shows that the samples taken from the Gujranwala
region also contain ﬁve constituents. Fig. 6 shows the names
of these constituents which were obtained by searching thelibrary of American Academy of Forensic Science. The ﬁrst
constituent is acenaphthol. The second constituent is
D9tetrahydrocanna- bivarin. The third constituent is cannabid-
iol. It is one of the major constituents of the cannabis plant.
It is supposed to have a wider scope than THC because it is less
psychoactive. Its molecular formula is C21H30O2. It is used in
the treatment of nausea, convulsions, bipolar disorders, etc.
The fourth constituent is tetrahydrocannabinol also known
as D9THC which is considered the main or principal
psychoactive constituent of the cannabis plant. It is classiﬁed
as schedule 1 under the convention on psychotropic
substances. It is available in a synthetic form as well, its brand
name is Marinol. It is a toxic component and can cause death
due to over dosing. The ﬁfth constituent is cannabinol. It is
usually present in trace amounts in C. sativa.
Figure 3 GCMS of Bhakkar sample.
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Pie Chart of Kashmir Sample  Following are the results of the GCMS analysis of the
Cannabis extract from the District of Chaman of Pakistan.
Fig. 7 reveals that the samples taken from the Chaman
region also contain ﬁve constituents. Fig. 8 reveals the
names of these constituents which were obtained by search-
ing the library of the American Academy of Forensic
Science. The ﬁrst constituent is azapyrene. The second con-
stituent is D9tetrahydrocannabivarin. The third constituent is
cannabidiol. It is one of the major constituents of the can-
nabis plant. It is supposed to have a wider scope than
THC because it is less psychoactive. Its molecular formula
is C21H30O2. It is used in the treatment of nausea, convul-
sions, bipolar disorders, etc. The fourth constituent is
tetrahydrocannabinol also known as D9THC which is con-
sidered the main or principal psychoactive constituent of
the cannabis plant. It is classiﬁed as schedule 1 under the
convention on psychotropic substances. It is available in a
synthetic form as well, its brand name is Marinol. It is a
toxic component and can cause death due to over dosing.
The ﬁfth constituent is cannabinol. It is usually present in
trace amounts in C. sativa (see Tables 1–5).
Figure 4 Library search of Bhakkar sample.
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Figure 5 GCMS of Gujranwala sample.
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Figure 6 Library search of Gujranwala sample.
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Figure 7 GCMS of Chaman sample.
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Figure 8 Library search of Chaman sample.
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Table 1 GCMS results of Kashmir sample.
Peak number Retention time Name of constituent Peak area
1 5.213 Phytol 6.04
2 5.665 9-Anthracenecarbonitrile 7.54
3 6.390 Cannabidiol 62.54
4 6.703 Delta-9-tetrahydrocannabinol 9.83
5 6.917 Cannabinol 14.05
Table 2 GCMS results of Bhakkar sample.
Peak number Retention time Name of constituent Peak area
1 5.213 Phytol 5.38
2 5.665 9-Anthracenecarbonitrile 7.18
3 6.384 Cannabidiol 64.13
4 8.90 Delta-9-tetrahydrocannabinol 8.90
5 6.911 Cannabinol 14.41
Table 3 GCMS results of Gujranwala sample.
Peak number Retention time Name of constituent Peak area
1 5.671 Acenaphthol 8.07
2 6.024 Delta-9-tetrahydrocannabivarin 6.38
3 6.395 Cannabidiol 58.66
4 6.708 Delta-9-tetrahydrocannabinol 14.13
5 6.917 Cannabinol 12.75
Table 4 GCMS results of Chaman sample.
Peak number Retention time Name of constituent Peak area
1 5.665 4-Azapyrene 5.665
2 6.018 Delta-9-tetrahydrocannabivarin 6.018
3 6.372 Cannabidiol 62.04
4 6.697 Delta-9-tetrahydrocannabinol 6.69
5 6.905 Cannabinol 6.905
Table 5 Constituents of different samples.
Serial No. Constituents Samples
1 Cannabinol All samples
2 Cannabidiol All samples
3 Delta-9-tetrahydrocannabinol All samples
4 Phytol Bhakkar, Kashmir
5 9-Anthracenecarbonitrile Bhakkar, Kashmir
6 4-Azapyrene Chaman
7 Delta-9-tetrahydrocannabivarin Gujranwala, Chaman
8 Acenaphthol Gujranwala
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The Cannabis samples obtained from the different areas of
Pakistan are only slightly different from each other. All four
samples contain the main psychoactive constituent D9THC
which is the most abundant in all four samples. The con-
stituents of the samples obtained from the two regions,
Bhakkar and Kashmir, are similar. Cannabinol and
Cannabidiol are also present in all four samples. This study
can help the researcher to identify the origin of the cannabis
plant.Funding
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